Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells in Rotator Cuff Repair
NCT03362424Phase 2Suspended
- Sponsor
- Universidade de São Paulo
- Start
- Nov 2020
- Primary completion
- Dec 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mesenchymal stem cells in rotator cuff tear (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Post-operative MRI tendon integrity at 6 months. Started Nov 2020; status: suspended.
02
Drugs
mesenchymal stem cells
03
Conditions
rotator cuff tear
Beyond the preview
Go deeper on NCT03362424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03362424.